GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+12.02%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$303M
AUM Growth
+$303M
Cap. Flow
-$21.4M
Cap. Flow %
-7.06%
Top 10 Hldgs %
43.19%
Holding
69
New
16
Increased
8
Reduced
15
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OTIC
51
DELISTED
Otonomy, Inc.
OTIC
$864K 0.25% 450,000
CASI icon
52
CASI Pharmaceuticals
CASI
$35.8M
$774K 0.23% 650,000
BNTX icon
53
BioNTech
BNTX
$24B
$546K 0.16% +2,000 New +$546K
TBIO
54
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$390K 0.11% 35,000
PRVB
55
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$320K 0.09% 50,000 -50,000 -50% -$320K
BIIB icon
56
Biogen
BIIB
$19.4B
-32,500 Closed -$11.3M
BYSI icon
57
BeyondSpring
BYSI
$69.4M
0
CRIS icon
58
Curis
CRIS
$20.9M
-247,124 Closed -$1.99M
ELEV
59
DELISTED
Elevation Oncology
ELEV
-100,000 Closed -$1.36M
EPIX icon
60
ESSA Pharma
EPIX
$11.4M
-207,500 Closed -$5.93M
GLPG icon
61
Galapagos
GLPG
$2.07B
-75,000 Closed -$5.17M
IMVT icon
62
Immunovant
IMVT
$2.56B
0
IWM icon
63
iShares Russell 2000 ETF
IWM
$67B
0
MRSN icon
64
Mersana Therapeutics
MRSN
$36.5M
-450,000 Closed -$6.11M
TGTX icon
65
TG Therapeutics
TGTX
$4.65B
-180,000 Closed -$6.98M
XBI icon
66
SPDR S&P Biotech ETF
XBI
$5.07B
0
CERE
67
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-75,000 Closed -$1.92M
TRIL
68
DELISTED
Trillium Therapeutics Inc.
TRIL
-1,250,000 Closed -$12.1M
KDMN
69
DELISTED
Kadmon Holdings, Inc.
KDMN
-800,000 Closed -$3.1M